🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Jeremy Grantham’s QLTY Holdings & Trades

First Buy
Q4 2025
Duration Held
1 Quarters
Largest Add
Q4 2025
+49,728 Shares
Current Position
49,728 Shares
$1.91 M Value

Jeremy Grantham's QLTY Position Overview

Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 49,728 shares of GMO US Quality ETF (QLTY) worth $1.91 M, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.

Based on recent 13F filings, Jeremy Grantham has initiated a new position in QLTY, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

Jeremy Grantham's GMO US Quality ETF (QLTY) Holding Value Over Time

Track share changes against reported price movement

Quarterly GMO US Quality ETF (QLTY) Trades by Jeremy Grantham

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +49,728 New Buy 49,728 $38.46

Jeremy Grantham's GMO US Quality ETF Investment FAQs

Jeremy Grantham first purchased GMO US Quality ETF (QLTY) in Q4 2025, acquiring 49,728 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeremy Grantham has held GMO US Quality ETF (QLTY) for 1 quarters since Q4 2025.

Jeremy Grantham's largest addition to GMO US Quality ETF (QLTY) was in Q4 2025, adding 49,728 shares worth $1.91 M.

According to the latest 13F filing for Q4 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 49,728 shares of GMO US Quality ETF (QLTY), valued at approximately $1.91 M.

As of the Q4 2025 filing, GMO US Quality ETF (QLTY) represents approximately 0.00% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.

Jeremy Grantham's peak holding in GMO US Quality ETF (QLTY) was 49,728 shares, as reported at the end of Q4 2025.